一种自组装的纳米粒子疫苗产生了有效的中和抗体反应,对抗EBV感染
Ping Li1,2, Ziyi Jiang1, Jingjing Shi1
1Institute of Biopharmaceutical and Health Engineering, Tsinghua Shenzhen International Graduate School, Tsinghua University, Shenzhen, China.
Frontiers in immunology
|January 20, 2025
概括
一种新的爱斯坦-巴尔病毒 (EBV) 候选疫苗,L350-ferritin纳米粒子,在小鼠中有效诱导中和抗体和B细胞记忆,有望预防EBV感染.
科学领域:
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
- 疫苗开发 疫苗开发
背景情况:
- 爱斯坦-巴尔病毒 (EBV) 感染了全球90%以上的人口,与癌症和自身免疫性疾病有关.
- 目前,没有批准针对EBV的有效预防性疫苗,这凸显了大量未满足的医疗需求.
研究的目的:
- 开发一种新的EBV候选疫苗,使用gp350糖蛋白的受体结合域中的表位.
- 评估开发的L350-ferritin纳米粒子候选疫苗的免疫性和有效性.
主要方法:
- 来自EBV gp350的Epitope被融化并以E. coli中的重组蛋白 (L350) 来表达.
- 在基于费里的纳米颗粒上显示了L350蛋白,其免疫性在Balb/c小鼠中进行了测试.
- 中和抗体标位使用体外感染阻断试验测量.
主要成果:
- L350-ferritin纳米粒子在其表面成功呈现了化表位.
- 免疫接种诱导了高标位的特定抗体和强大的中和抗体对抗EBV感染在体外.
- 候选疫苗产生了强大的抗原特异性B细胞记忆,没有观察到不良的组织病理变化.
结论:
- L350-ferritin纳米颗粒候选疫苗显示出预防EBV感染的巨大潜力.
- 这项研究为未来预防性EBV疫苗的开发提供了有希望的基础.
更多相关视频
00:10Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
Published on: August 21, 2019
7.5K
05:15Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle VLP-Based Vaccines Using a Capture Assay
Published on: February 10, 2022
3.5K
相关概念视频
Cross-reactivity
Overview
Immune Response Against Viral Pathogens
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
